Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
Evaluation of the satiating and probiotic effect of goat cheese in volunteers on a weight control regimen: A randomized controlled trial
View current
Revisions
List all revisions
View
Compare to current
17 November 2025 - 2:46pm
by Gladys
13 December 2025 - 12:15pm
by Gladys
Changes to
Record Verification Date
-
2025/
11
/
17
+
2025/
12
/
13
Changes to
Next update date
-
2026/
11
/
17
+
2026/
12
/
13
Revision of 13 December 2025 - 12:15pm:
Evaluation of the satiating and probiotic effect of goat cheese in volunteers on a weight control regimen: A randomized controlled trial
General information
Section to complete general information about the trial: scientific and public title, protocol identifiers, sponsors and Source(s) of Monetary or Material Support.
Acronym of Public Title:
NUTRICHEESE
Scientific title:
Evaluation of the satiating and probiotic effect of goat cheese in volunteers on a weight control regimen: A randomized controlled trial
Acronym of Scientific Title:
NUTRICHEESE
Secondary indentifying numbers:
Not applicable
Issuing authority of the secondary identifying numbers:
Not applicable
Primary sponsor:
Genomic Biotechnology Center – National Polytechnic Institute (IPN-Reynosa), Mexico
Secondary sponsor:
Not applicable
Source(s) of monetary or material support:
National Polytechnic Institute (IPN) SIP 20250980
Authorization for beginning
Section to complete information about the regulatory approval of clinical trial: regulatory agency name, approval date and reference number in the agency.
Regulatory instance to authorize the initiation of the study:
Only approved by Ethics Committees
Principal investigator
Section to complete information about Email address, telephone number and postal address of the Principal Investigator.
First name:
Ana
Midle name:
Maria
Last name:
Sifuentes Rincon
Medical Specialty :
Biomedical Researcher in Animal Digestive Nutrigenomics and Microbiomics
Affiliation:
Genomic Biotechnology Center – National Polytechnic Institute
Postal address:
Boulevard del Maestro N/A, Narciso Mendoza
City:
Reynosa
Country:
Mexico
Zip Code:
88710
Telephone:
+52-8999243627
ext.
87723
Email address:
asifuentes@ipn.mx
Clinical sites to participate
Section to complete the data related to the clinical sites involved in the trial: site and responsible investigator for every site.
Countries of recruitment:
Mexico
Clinical sites:
Not applicable
Recruitment status
Section to complete information about the recruitment status and the date of first enrolment subject
Recruitment status:
Pending
Date of first enrollment:
19/11/2025
Health condition and Intervention
Section to complete information about the primary medical condition(s) or problem(s) studied and, a characteristics of the intervention(s).
Health condition(s) or Problem(s) studied:
Overweight and obesity
Health condition(s) code:
Healthy Volunteers
Obesity
Overweight
Nutrition Disorders
Nutritional and Metabolic Diseases
Body Weight
Intervention(s):
Group A (Experimental): 80 g of goat cheese with lower content of fat three days a week for fourth weeks, prohibited consuming milk, yogurt, cheese. Group B (Control): 80 g of goat cheese with higher content of fat three days a week for fourth weeks, prohibited consuming milk, yogurt, cheese.
Intervention code:
Cheese
Diet, Food, and Nutrition
Intervention keyword:
goat cheese
Outcomes and Timepoint
Section to complete information about primary and secondary outcomes including. It includes the metric or method of measurement used and, the time point for every outcome.
Primary outcome(s):
Acylated ghrelin. Measurement time: At the beginning and 4 weeks (before breakfast, at minute 30 and 120 after finishing breakfast).
Key secondary outcomes:
Anthropometric measurements and indexs: Weight (in Kg), Waist circumference (in cm), Abdominal circumference (in cm), Hip circumference (in cm), Waist-hip ratio (waist circumference/hip circumference in cm), Body Mass Index-BMI (Weight/(Height*Height). (Weight measured in Kg and height in m) measurement time: At baseline, at 2 and 4 weeks. Satiety (VAS) Measurement time: before breakfast, at minute 30 and 120 after finishing breakfast. Bacterial diversity Measurement time: at baseline, at 2, 3 and 4 weeks. Plasma lipid profile (Total cholesterol, Triglycerides, very low, low and high density lipoproteins (values in mg/dL)), measurement time: At baseline and 4 weeks. Nutrigenetic and nutrigenomic analysis measurement time: At baseline and 4 weeks. HOMA-IR index, measurement time: At baseline and 4 weeks.
Selection criterias
Section to complete information about the inclusion and exclusion criteria for participant selection, including age and gender.
Gender:
Male/Female
Minimum age:
18 years
Maximum age:
55 years
Inclusion criteria:
1. Adults: Women and Men 2. Nationality of any kind 3. Body mass index ≥25 4. Age: 18–55 years 5. Clinically healthy 6. Subjects from any socioeconomic or cultural group 7. Able to be informed about the study and willing to accept and sign written informed consent prior to the study 8. Consume goat cheese
Exclusion criteria:
1. Allergic and/or lactose intolerant 2. Type I or II diabetes 3. High blood pressure (defined as systolic blood pressure ≥140 or diastolic blood pressure ≥90 mmHg) 4. Cardiovascular disease, chronic kidney disease 5. Hyperlipidemia 6. Alcoholism and/or drug dependence 7. Smoker (>10 cigarettes per day) 8. Women who are pregnant or breastfeeding 9. Undergoing any medical treatment 10. Use of anorectic agents that act on the adrenergic, serotonergic, and adrenergic/serotonergic pathways. 11. Use of medications or supplements. 12. Insufficient motivation, as assessed by the interview, to remain in the clinical trial. 13. The volunteer no longer wishes to participate in the study 14. Inability to comply with the instructions of the investigation
Type of population:
Adults
Type of participant:
Healthy volunteers
Study design
Section to complete information about the characteristics of the study design.
Type study:
Interventional
Purpose:
Screening
Allocation:
Randomized controlled trial
Masking:
Double Blind
Control group:
Active
Study design:
Parallel
Phase:
N/A
Target sample size:
20
Contact for public queries
Section to complete information about Email address, telephone number and postal address of the contact who will respond to general queries, including information about current recruitment status
First Name:
Diana
Middle Name:
Alejandra
Last Name:
Vela Vasquez
Specialty:
Human nutrition
Affiliation:
Genomic Biotechnology Center – National Polytechnic Institute
Postal Address:
Blvrd del Maestro N/A, Narciso Mendoza
City:
Reynosa
Country:
Mexico
Zip Code:
88710
Telephone:
+52-8999243627
Email :
diana.w@outlook.com
Contact for scientific queries
Section to complete information about Email address, telephone number and postal address of the contact who will respond to scientific queries.
First Name:
Ana
Middle Name:
Maria
Last Name:
Sifuentes Rincon
Specialty:
Biomedical Researcher in Nutrigenomics and Animal Digestive Microbiotics
Affiliation:
Genomic Biotechnology Center – National Polytechnic Institute
Postal Address:
Boulevard del Maestro N/A, Narciso Mendoza
City:
Reynosa
Country:
Mexico
Zip Code:
88710
Telephone:
+52-8999243627
Email :
asifuentes@ipn.mx
Data Sharing
Section to complete the data related to the data sharing plan.
Data sharing plan:
No
Research Ethics Committees
Section to complete the data related to the review ethics committees.
Name of Research Ethics Committees:
Comité de Bioética de la Facultad de Medicina de la Universidad de Colima
Status of evaluation:
Approved
Status of evaluation date of Ethic Committee:
06/05/2025
Postal address of Ethic Committee :
Avenida Universidad 333, Colonia Las Viboras, Colima C.P:28040, Mexico
Telephone:
+52-3123161099
Email:
medicina@ucol.mx
About study completion
Section to complete the data related to the study completion.
Final enrolment number:
0
Study completion date:
19/12/2025
Registration and Update
Section to complete information about the name of Primary Registry, date of registration and the unique ID number assigned by the registry (RPCEC).
Primary registry:
RPCEC
Unique ID number:
RPCEC00000462
Date of Registration in Primary Registry:
17/11/2025
Record Verification Date:
2025/12/13
Next update date:
2026/12/13
Link to the spanish version:
Click here
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform